Animal models in peritoneal dialysis by Olga Nikitidou et al.
MINI REVIEW
published: 01 September 2015
doi: 10.3389/fphys.2015.00244
Frontiers in Physiology | www.frontiersin.org 1 September 2015 | Volume 6 | Article 244
Edited by:
Ali Mobasheri,
University of Surrey, UK
Reviewed by:
Martin Diener,
Giessen University, Germany
David Marples,
University of Leeds, UK
*Correspondence:
Vassilios Liakopoulos,
Division of Nephrology and
Hypertension, 1st Department of
Internal Medicine, School of Medicine,
American Hellenic Educational
Progressive Association Hospital,
Aristotle University of Thessaloniki,
1 St. Kyriakidi street, 54636,
Thessaloniki, Greece
liakopul@otenet.gr
Specialty section:
This article was submitted to
Membrane Physiology and Membrane
Biophysics,
a section of the journal
Frontiers in Physiology
Received: 21 June 2015
Accepted: 17 August 2015
Published: 01 September 2015
Citation:
Nikitidou O, Peppa VI, Leivaditis K,
Eleftheriadis T, Zarogiannis SG and
Liakopoulos V (2015) Animal models
in peritoneal dialysis.
Front. Physiol. 6:244.
doi: 10.3389/fphys.2015.00244
Animal models in peritoneal dialysis
Olga Nikitidou 1, Vasiliki I. Peppa 2, Konstantinos Leivaditis 1, Theodoros Eleftheriadis 1,
Sotirios G. Zarogiannis 2 and Vassilios Liakopoulos 1*
1Division of Nephrology and Hypertension, 1st Department of Internal Medicine, School of Medicine, American Hellenic
Educational Progressive Association Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, 2Department of
Physiology, Faculty of Medicine, BIOPOLIS, University of Thessaly, Larissa, Greece
Peritoneal dialysis (PD) has been extensively used over the past years as a method
of kidney replacement therapy for patients with end stage renal disease (ESRD). In
an attempt to better understand the properties of the peritoneal membrane and the
mechanisms involved in major complications associated with PD, such as inflammation,
peritonitis and peritoneal injury, both in vivo and ex vivo animal models have been used.
The aim of the present review is to briefly describe the animal models that have been
used, and comment on themain problems encounteredwhile working with thesemodels.
Moreover, the differences characterizing these animal models, as well as, the differences
with humans are highlighted. Finally, it is suggested that the use of standardized protocols
is a necessity in order to take full advantage of animal models, extrapolate their results
in humans, overcome the problems related to PD and help promote its use.
Keywords: animal models, ion and water transport, membrane physiology, peritoneal dialysis, ussing chamber
Peritoneal dialysis (PD) is a well-established method of kidney replacement therapy. It is
currently estimated that the end stage renal disease (ESRD) patients receiving PD worldwide are
approximately 200,000 and that they represent 11% of the total number of patients receiving any
modality of dialysis (Jain et al., 2012). It is worth mentioning that Putman in 1923 made the first
attempt for PD in a canine model (Putnam, 1923).
The extended use of PD over the years makes the in depth understanding of the physiology of the
peritoneal membrane, the transport of solute and water across it and the mechanisms influencing
inflammation, peritonitis, peritoneal injury and encapsulating peritonitis, a necessity. Moreover,
many therapeutic interventions, new PD solutions, and pharmaceutical agents need to be tested
before their implementation in the daily clinical practice. Research on humans could probably
provide the necessary answers to the aforementioned topics, but it is complicated with many
technical problems and ethical concerns (Stojimirovic et al., 2007). The scientific community in
order to overcome this problem has exploited the observed similarities among humans and animal
models. More precisely, the similar transport properties of solute and water across the peritoneal
membrane in humans and animal models was an important foundation for the conduction of series
of experiments in a variety of animal models.
Small animals such as rats, rabbits, and genetically modified mice have mostly been used for
experimental models, although larger animals such as dogs, sheep, or even kangaroos have been
used, as well. The use of each animal model comes with different advantages and disadvantages
(Table 1). More precisely, rats are easy to breed and affordable, but have a short life expectancy,
small size that increases the risk of complications during the insertion of a peritoneal catheter and
large size of peritoneal membrane when at the same time only small quantities of dialysate can be
introduced in their peritoneal cavity (Lameire et al., 1998). On the other hand, rabbits have a longer
life expectancy, can survive longer on PD and the insertion of the peritoneal catheter is easier,
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TABLE 1 | Main advantages and disadvantages of different animals used in animal models.
Animals Advantages Disadvantages
Small Rats • Easy and affordable breeding
• Fast generation and maturation
• Short life expectancy
• Small size—increased risk of complications
• Higher ratio of peritoneal surface area compared to humans
• Large size of parietal peritoneum
• High intraperitoneal amylase levels
Rabbits • Adequate life expectancy
• Adequate survival on PD
• Easy peritoneal catheter insertion
• Similar size of parietal peritoneum to humans
• Similar ratio of peritoneal surface area to humans
• Delicate animals—difficult to breed
Genetically
modified mice
• Easy and affordable breeding
• Fast generation and maturation
• Ability to explore the role of single proteins
• Extremely small size
Large Dogs
Sheep
Kangaroos
etc
• Long life expectancy
• Easy peritoneal catheter insertion
• Difficult and expensive breeding
• Large time frame for obtaining results
but are very delicate animals and difficult to breed (Garosi and
Di Paolo, 2001). Regarding larger animals, their life expectancy is
long and could approximate PD on humans, but their breeding is
difficult and expensive and a large time frame is needed for results
to be obtained (Van Biesen et al., 2006).
As for the genetically modified mice, both knockout and
transgenic models have been used over the past few years in order
to provide important information in many different molecular
pathways that are significant for PD (Nishino et al., 2007). The
ability to modify the genome of mice enabled the scientists to
explore the expression of different genes and the results of the
modification of their expression. The role of single proteins such
as aquaporin-1 in the transport of water across the peritoneal
membrane (Yang et al., 1999; Ni et al., 2006) or NOS (Nitric
oxide synthase) isoforms in peritonitis (Ni et al., 2010), as well
as, IL-6 in inflammation (Hurst et al., 2001; McLoughlin et al.,
2004) and TGF-β in encapsulating peritonitis (Park et al., 2008)
were explored using genetically modified mice. The extremely
small size of these animal makes manipulations difficult (Ni
et al., 2003), but over the past few years the development of new
molecular techniques provide significant tools to overcome this
disadvantage (Devuyst et al., 2010).
Acute and chronic animal models have been developed (Hoff,
2005; Pawlaczyk et al., 2015) (Table 2). Acute models describe
experiments that have short duration and can study the impact of
a single dwell on the peritoneal membrane. They provide crucial
information regarding mainly the transport characteristics of
the peritoneal membrane and its function. Its permeability to
water and solute, the interaction with different dialysis solutions,
certain substances, therapeutic agents or even inflammation
mediators can be extensively studied this way. On the other
hand, chronic models can evaluate the chronic impact of PD
resembling the impact of the method on humans due to the
longer duration of the experiments. They can focus on changes
of the structure and the function of the peritoneal membrane. For
example, the effect of glucose used as an osmotic agent in dialysis
solutions or the effect of the newer biocompatible solutions
with lower GDPs’ (Glucose degradation products) concentration,
neutral pH or replacement of glucose with icodextrin on the
morphology of the peritoneal membrane can be analyzed.
Fibrosis, encapsulating peritoneal sclerosis, repeated episodes of
peritonitis, andmorphological alterations can be in depth studied
using the chronic models. In this way, an important background
for targeted therapeutic interventions is provided.
In the acute model the animal is anesthetized, a temporary
catheter is inserted in the peritoneal cavity and during a 4-h dwell
samplings of the peritoneal fluid and blood are obtained (Lameire
et al., 1998). In the chronic model, on the other hand, three
are the most common methods used (Mortier et al., 2005). The
first method includes the direct blind injection of the dialysate
into the peritoneal cavity with or without anesthesia. The
repeated injections are related to increased risk of intraperitoneal
bleeding and infection that could probably interfere with the
results of the experiment. The second method is called “open
system” and is characterized by the subcutaneous insertion of a
permanent indwelling peritoneal catheter from the neck to the
peritoneal cavity of the animal. This catheter can be used for
the introduction of dialysate into the peritoneal cavity and the
drain of the dwell directly or indirectly as it can be used as the
tunnel through which another sterile catheter is inserted during
every exchange. In this method anesthesia is not required but
the rate of peritonitis episodes remains high and the malfunction
of the catheter as a result of omental wrapping, adhesions and
fibrosis is frequent. Finally, the third method is called “closed
system.” In this method, as in the “open-system,” a permanent
indwelling peritoneal catheter is inserted subcutaneously from
the neck to the peritoneal cavity of the animal. The catheter is
attached to a subcutaneous reservoir in the neck of the animal
and the dialysate remains in the peritoneal cavity until it is
fully absorbed. This method results in lower rates of peritonitis,
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TABLE 2 | The main studied parameters in acute and chronic animal
models.
Animal Studied parameters
models
Acute Transport characteristics and
function of the PM
Permeability to water and solutes
Lymphatic drainage
Interaction with different dialysis
solutions
Acute effect of glucose
Inflammatory response—effect of
inflammation mediators
Interaction with various therapeutic
agents
Chronic Changes of structure and
function of the PM
Effect of biocompatible solutions
(lower GDP and neutral pH)
Effect of icodextrin
Peritonitis—defense mechanisms
Mesothelial cell damage
PM thickness
Vascular alterations
Fibrosis
Encapsulating peritoneal sclerosis
Therapeutic interventions
PM, peritoneal membrane.
although the malfunction of the catheter still remains a
problem.
In any case, even if it is tempting, before applying the
extrapolated results of animal models in humans we should
point out the differences between these models and humans and
the related technical problems. The most important differences
concern the visceral, parietal and diaphragm surfaces. It seems
that the diaphragm, which is directly related to the lymphatic
drainage responsible for the clearance of macromolecules,
extends to a larger area in humans than in animal models
(Pawlaczyk et al., 2015). On the other hand, the parietal
peritoneum that is directly related to the solute transport is
larger in rats than in humans, while in rabbits it is similar to
humans (Pawlaczyk et al., 1996). Moreover, it is known that
the intraperitoneal levels of amylase that are elevated in rats
can locally degrade icodextrin, an osmotic agent used in several
dialysis fluids, rapidly (deWaart et al., 2001). To these differences
one must add the higher ratio of peritoneal surface area to
dialysate that is observed in rats, while in rabbits it is similar to the
one observed in humans (Stojimirovic et al., 2007). Finally, in rats
changes in the permeability and the surface area of the peritoneal
membrane are encountered as they grow up, resulting in changes
in the kinetics of the peritoneal membrane (Kuzlan et al., 1997).
As Van Biesen et al highlights multiple experiments in different
animal models and comparison of the results obtained could
overcome those differences and provide amore realistic approach
of the mechanisms that characterize PD in humans (Van Biesen
et al., 2006).
Among the technical problems that have to be faced when
handling animal models, tissue-sampling problems must be
highlighted. The peritoneal tissue is quite fragile, dries quickly
when exposed to the air and can easily be damaged even after
delicate contact with surgical gloves or instruments (Duman
and Sen, 2009). Furthermore, in patients on PD the visceral
peritoneum exhibits more pronounced alterations than the
parietal peritoneum, while in many of the studies conducted
in animal models the biopsy samples are obtained by the
parietal peritoneum. This inconsistency could be misleading if
extrapolating results of animal studies to humans.
Catheter obstruction, peritonitis, and anesthesia use represent
other major problems. In an attempt to minimize catheter
dysfunction, omentectomy, and heparin have been used, but both
methods have important pitfalls. On one hand the omentum
is considered to be an important immune defense organ of
the peritoneal cavity (Beelen, 1992), while on the other heparin
is known to have many pleiotropic actions besides being an
anticoagulant (De Vriese et al., 2001; Gozdzikiewicz et al.,
2009). Therefore, both of these interventions could result
in undesirable functional and morphological changes in the
peritoneum (Mortier et al., 2005). The use of heparin coated
catheters that has been suggested seems to be a good solution,
since it reduces the rate of malfunction without inducing
changes in the peritoneum (De Vriese et al., 2002). Regarding
peritonitis, many investigators have administered antibiotics in
order to prevent infections, an intervention that has been proven
successful and simultaneously not leading to morphological and
function changes in the peritoneum (Mortier et al., 2003; Choi
et al., 2006). Finally, the use of anesthesia when handling animals
has been related to changes in the peritoneum kinetics, probably
through a direct reduction of the lymphatic drainage (Tran
et al., 1993) and an increase of ultrafiltration and decrease of
the absorption rates from the peritoneal membrane (Shin et al.,
2006).
There are some important differences in animal model studies
(Mortier et al., 2005; Topley, 2005). There are differences related
to the volume of dialysate instilled and the time it remains in the
peritoneal cavity, the frequency of the exchanges, and the total
time the animals undergo PD before the termination of the study.
The drainage of the dialysate is also an issue. More precisely,
there are animal models characterized by the presence of the
dialysate in the peritoneal cavity until it is fully absorbed, while
in other animal models drainage after every dwell is performed.
The last model resembles chronic PD in humans and offers the
ability to better understand transportation through the peritoneal
membrane and at the same time examine the dialysate for
the presence of cells and substances (Pawlaczyk et al., 2015).
Moreover, differences in the use of anesthesia, heparin or even the
definition of peritonitis have been described. A common finding
in most studies is the use of high concentration glucose solutions
although in humans other lower glucose concentration solutions
may also be used. Finally, the high rate of dropout due to
catheter malfunction must be highlighted. It is obvious that there
are many limitations when analyzing the results of the studies
conducted on animal models, nevertheless the information they
provide are very important and necessary to better understand
this method of renal replacement therapy.
One field of special interest for nephrologists is encapsulating
peritoneal sclerosis (EPS) which is a rare but life threatening
complication of PD. Several animal models have been used
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in order to understand the underlying pathophysiological
mechanisms that lead to EPS (Hoff, 2005; Park et al., 2008;
Hirahara et al., 2015). Chlorexidine and acidic dialysis solutions,
povidone iodine, formaldehyde, and even bleach and talc are
some of the agents that have been used in an attempt to induce
peritoneal injury and development of EPS in animal models.
At the same time many different inhibitors of inflammation,
angiogenesis, and fibrosis, as well as, inhibitors of the renin
angiotensin system have been studied as potential therapeutic
interventions in an attempt to resolve EPS (Kitamura et al.,
2014).
The in vivo animal models provide useful information for
future PD solutions that are yet to be tested or promote our
understanding of their effects on the peritoneal membrane
of ESRD patients undergoing PD. To this end an ex vivo
sheep and human model of the peritoneal ionic and water
permeability can further provide useful information that can be
applied in the PD solution improvement and development area
(Liakopoulos et al., 2006, 2009). In these studies the membrane
specimens are mounted in the Ussing System that measures
the transmembrane ionic permeability (Zarogiannis et al., 2004;
Stefanidis et al., 2005). The majority of such investigations
involved electrophysiological experiments in sheep visceral or
parietal peritoneum specimens and some of the results have
been tested in human specimens yielding identical findings, thus
rendering this model a powerful tool for PD solution assessment
as to the ion and water transport drug induced alterations
(Zarogiannis et al., 2005, 2007; Stefanidis et al., 2007). The focus
of these electrophysiological investigations was the identification
of ion channels, as well as, hormonal receptors present in the
mesothelial compartment of the peritoneum (Kourti et al., 2007,
2013; Zarogiannis et al., 2007; Karioti et al., 2008, 2009). Most of
these findings remain yet to be investigated in human specimens
and subsequently tested in in vivo animal models.
In conclusion, in vivo and ex vivo animal models have been
extensively used for the understanding of the properties of the
peritoneal membrane and results of these experiments have been
extrapolated in humans. For the time being, the fundamental
differences in the animal models used, as already described,
remains the main problem when it comes to comparing results
of different models and especially using these results in order to
evaluate the use of PD in humans. At the same time, the necessity
of in depth understanding of PD brings into perspective
the importance of establishing standardized protocols
that could overcome the aforementioned differences and
obstacles.
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